As reported by Business Weekly, the US real estate investment company, BioMed Realty Trust, has acquired Granta Park, a leading science park based in Cambridge for £126.8m.
Currently, the Cambridge-based Science Park as 11 lab and office buildings and it’s tenants include some of the worlds leading pharma and biotech organisations including Gilead Sciences, UCB and Vernalis. The investment from BioMed Realty will also current tenant relationships with companies such as MedImmune and Pfizer to be extended.
Speaking of the agreement, BioMed Realty stated, “The Cambridge UK research community is anchored by the University of Cambridge, established in 1209, with 20 per cent of the world’s Nobel Prize recipients in medicine and chemistry and the recipient of over 280 million pounds in research grants in 2011.
“This Cambridge science cluster supports over 1,000 science and technology companies, the Wellcome Trust, the largest medical research charitable organisation in the world, Cavendish Laboratory, and the Babraham Institute.”
